David Jayne
Impact in
- Rheumatology top 0.01%
- Systemic Lupus Erythematosus Research
- Otitis Media and Relapsing Polychondritis
- Urticaria and Related Conditions
- Nephrology top 0.02%
- Renal Diseases and Glomerulopathies
Papers in
-
- Vasculitis and related conditions 367
- Rheumatology 221
- Systemic Lupus Erythematosus Research 92
- Otitis Media and Relapsing Polychondritis 83
- Urticaria and Related Conditions 40
- Co-authors
- Raashid Luqmani (61 shared papers)Rachel Jones (49 shared papers)Kerstin Westman (37 shared papers)Niels Rasmussen (28 shared papers)Charles D. Pusey (24 shared papers)Michael Walsh (35 shared papers)C M Lockwood (23 shared papers)Peter A. Merkel (70 shared papers)
- Journals
- Lara D. Veeken (69 papers)Annals of the Rheumatic Diseases (50 papers)Nephrology Dialysis Transplantation (41 papers)Journal of the American Society of Nephrology (16 papers)Kidney International (14 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
David Jayne
507 papers receiving 33.3k citations
David Jayne's Hit Papers
Peers
Comparison fields: 5 of 172
- Rheumatology 12.2k
- Nephrology 5.4k
- Pulmonary and Respiratory Medicine 23.0k
- Genetics 5.8k
- Immunology 6.1k
Countries citing papers authored by David Jayne
This map shows the geographic impact of David Jayne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jayne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jayne more than expected).
Fields of papers citing papers by David Jayne
This network shows the impact of papers produced by David Jayne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jayne. The network helps show where David Jayne may publish in the future.
Co-authors
The 25 scholars most cited alongside David Jayne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 536 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis Hit paper breakdown → | 2010 | 1185 |
| 2 | A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies Hit paper breakdown → | 2003 | 996 |
| 3 | Modification and validation of the Birmingham Vasculitis Activity Score (version 3) Hit paper breakdown → | 2008 | 836 |
| 4 | Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis Hit paper breakdown → | 2009 | 803 |
| 5 | Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis Hit paper breakdown → | 2007 | 773 |
| 6 | EULAR recommendations for the management of primary small and medium vessel vasculitis Hit paper breakdown → | 2008 | 690 |
| 7 | Long-term patient survival in ANCA-associated vasculitis Hit paper breakdown → | 2010 | 680 |
| 8 | Histopathologic Classification of ANCA-Associated Glomerulonephritis Hit paper breakdown → | 2010 | 623 |
| 9 | Avacopan for the Treatment of ANCA-Associated Vasculitis Hit paper breakdown → | 2021 | 593 |
| 10 | Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis Hit paper breakdown → | 2005 | 579 |
| 11 | ANCA-associated vasculitis Hit paper breakdown → | 2020 | 547 |
| 12 | T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection Hit paper breakdown → | 2015 | 514 |
| 13 | Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome Hit paper breakdown → | 2005 | 501 |
| 14 | EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Hit paper breakdown → | 2006 | 475 |
| 15 | EULAR recommendations for the management of large vessel vasculitis Hit paper breakdown → | 2008 | 464 |
| 16 | Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis Hit paper breakdown → | 2011 | 460 |
| 17 | EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases Hit paper breakdown → | 2010 | 458 |
| 18 | Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis Hit paper breakdown → | 2017 | 449 |
| 19 | 1999 | 448 | |
| 20 | Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Hit paper breakdown → | 2010 | 411 |
About David Jayne
David Jayne is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Genetics, Immunology and Nephrology, having authored 536 papers that have together received 34.9k indexed citations. Recurring topics across this work include Vasculitis and related conditions (367 papers), Systemic Lupus Erythematosus Research (92 papers), Otitis Media and Relapsing Polychondritis (83 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (73 papers), Renal Diseases and Glomerulopathies (62 papers), Urticaria and Related Conditions (40 papers), Sarcoidosis and Beryllium Toxicity Research (35 papers) and Atherosclerosis and Cardiovascular Diseases (20 papers). The work is most often cited by research in Rheumatology (12.2k citations), Nephrology (5.4k citations), Pulmonary and Respiratory Medicine (23.0k citations), Genetics (5.8k citations) and Immunology (6.1k citations). David Jayne has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Raashid Luqmani, Rachel Jones, Kerstin Westman, Niels Rasmussen, Charles D. Pusey, Michael Walsh, C M Lockwood, Peter A. Merkel, Oliver Floßmann and Kirsten de Groot. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Nephrology Dialysis Transplantation, Journal of the American Society of Nephrology and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.